Thursday, July 27, 2017

COCA Call Today: Zika - Updated Clinical Guidance & Recommendations for Pregnant Women and Infants


Later today  the CDC will hold a COCA (Clinicians Outreach and Communication Activity) caall with their latest guidance and recommendations on Zika Virus infection in pregnant women and infants.
Primarily of interest to clinicians and healthcare providers, COCA (Clinician Outreach Communication Activity) calls are designed to ensure that practitioners have up-to-date information for their practices.
Follow the link below to review the different ways you can access this webinar.

Zika Virus: Updates to Clinical Guidance and Recommendations for Pregnant Women and Infants

Free Continuing Education 
Date:Thursday, July 27, 2017
Time: 2:00-3:00 pm (Eastern Time)
Please join the COCA Call webinar with digital audio, video and presentation formats from a PC, Mac, iPad, iPhone or Android device:

If you cannot join through digital audio, you may join by phone in listen-only mode: 1 646-558-8656 or 1 408-638-0968

Passcode: 974 205 265
International numbers are available:


CDC has updated its interim guidance for pregnant women with possible exposure to Zika virus to include separate recommendations for pregnant women with symptoms and pregnant women without symptoms. In addition, CDC recently released its latest findings from the Zika pregnancy and infant registries on pregnancy outcomes for pregnant women with Zika virus infection in the U.S. territories and has new updates for healthcare providers on pediatric ophthalmologic findings in infants with possible congenital Zika virus exposure. During this COCA Call, clinicians will learn about the recent updates to CDC’s interim guidance for pregnant women with possible exposure to Zika virus; hear about the latest findings on pregnancy outcomes in the U.S. territories, based on the Zika pregnancy and infant registries; and receive new information on pediatric ophthalmologic findings to assist in caring for patients based on currently available data.

No comments: